Literature DB >> 23358540

Adding risk factors for potentially resistant pathogens, increasing antibiotic pressure and risk creating the "untreatable bacteria": time to change direction.

José-Artur Paiva.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23358540     DOI： 10.1007/s00134-012-2811-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  12 in total

Review 1.  Molecular diagnosis of bloodstream infections: planning to (physically) reach the bedside.

Authors:  N Leggieri; A Rida; P François; Jacques Schrenzel
Journal:  Curr Opin Infect Dis       Date:  2010-08       Impact factor: 4.915

2.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

3.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

4.  Society's failure to protect a precious resource: antibiotics.

Authors:  Jean Carlet; Peter Collignon; Don Goldmann; Herman Goossens; Inge C Gyssens; Stephan Harbarth; Vincent Jarlier; Stuart B Levy; Babacar N'Doye; Didier Pittet; Rosana Richtmann; Wing H Seto; Jos W M van der Meer; Andreas Voss
Journal:  Lancet       Date:  2011-04-07       Impact factor: 79.321

Review 5.  De-escalation therapy: is it valuable for the management of ventilator-associated pneumonia?

Authors:  Michael S Niederman; Vasiliki Soulountsi
Journal:  Clin Chest Med       Date:  2011-09       Impact factor: 2.878

6.  Ventilator-associated pneumonia caused by potentially drug-resistant bacteria.

Authors:  J L Trouillet; J Chastre; A Vuagnat; M L Joly-Guillou; D Combaux; M C Dombret; C Gibert
Journal:  Am J Respir Crit Care Med       Date:  1998-02       Impact factor: 21.405

7.  Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors.

Authors:  Ignacio Martin-Loeches; Maria Deja; Despoina Koulenti; George Dimopoulos; Brian Marsh; Antonio Torres; Michael S Niederman; Jordi Rello
Journal:  Intensive Care Med       Date:  2013-01-29       Impact factor: 17.440

8.  Severity of ICU-acquired pneumonia according to infectious microorganisms.

Authors:  Pierre Damas; Nathalie Layios; Laurence Seidel; Monique Nys; Pierrette Melin; Didier Ledoux
Journal:  Intensive Care Med       Date:  2011-05-26       Impact factor: 17.440

9.  Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study.

Authors:  Karthikeyan K Kumarasamy; Mark A Toleman; Timothy R Walsh; Jay Bagaria; Fafhana Butt; Ravikumar Balakrishnan; Uma Chaudhary; Michel Doumith; Christian G Giske; Seema Irfan; Padma Krishnan; Anil V Kumar; Sunil Maharjan; Shazad Mushtaq; Tabassum Noorie; David L Paterson; Andrew Pearson; Claire Perry; Rachel Pike; Bhargavi Rao; Ujjwayini Ray; Jayanta B Sarma; Madhu Sharma; Elizabeth Sheridan; Mandayam A Thirunarayan; Jane Turton; Supriya Upadhyay; Marina Warner; William Welfare; David M Livermore; Neil Woodford
Journal:  Lancet Infect Dis       Date:  2010-08-10       Impact factor: 25.071

10.  Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria.

Authors:  Katherine E Kollef; Garrett E Schramm; Angela R Wills; Richard M Reichley; Scott T Micek; Marin H Kollef
Journal:  Chest       Date:  2008-08       Impact factor: 9.410
View more
  5 in total

1.  Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).

Authors:  Cédric Bretonnière; Marc Leone; Christophe Milési; Bernard Allaouchiche; Laurence Armand-Lefevre; Olivier Baldesi; Lila Bouadma; Dominique Decré; Samy Figueiredo; Rémy Gauzit; Benoît Guery; Nicolas Joram; Boris Jung; Sigismond Lasocki; Alain Lepape; Fabrice Lesage; Olivier Pajot; François Philippart; Bertrand Souweine; Pierre Tattevin; Jean-François Timsit; Renaud Vialet; Jean Ralph Zahar; Benoît Misset; Jean-Pierre Bedos
Journal:  Intensive Care Med       Date:  2015-06-03       Impact factor: 17.440

2.  Potential Impact of Flow Cytometry Antimicrobial Susceptibility Testing on the Clinical Management of Gram-Negative Bacteremia Using the FASTinov® Kit.

Authors:  Sofia Costa-de-Oliveira; Rita Teixeira-Santos; Ana P Silva; Elika Pinho; Paulo Mergulhão; Ana Silva-Dias; Nádia Marques; Inês Martins-Oliveira; Acácio G Rodrigues; José A Paiva; Rafael Cantón; Cidália Pina-Vaz
Journal:  Front Microbiol       Date:  2017-12-12       Impact factor: 5.640

3.  The antifungal potential of (Z)-ligustilide and the protective effect of eugenol demonstrated by a chemometric approach.

Authors:  Alice M S Rodrigues; Véronique Eparvier; Guillaume Odonne; Nadine Amusant; Didier Stien; Emeline Houël
Journal:  Sci Rep       Date:  2019-06-19       Impact factor: 4.379

4.  Short chain N-acylhomoserine lactone production by clinical multidrug resistant Klebsiella pneumoniae strain CSG20.

Authors:  Yun Fong Ngeow; Huey Jia Cheng; Jian Woon Chen; Wai-Fong Yin; Kok-Gan Chan
Journal:  Sensors (Basel)       Date:  2013-11-07       Impact factor: 3.576

5.  Tigecycline use in critically ill patients: a multicentre prospective observational study in the intensive care setting.

Authors:  Philippe Montravers; Hervé Dupont; Jean-Pierre Bedos; Philippe Bret
Journal:  Intensive Care Med       Date:  2014-05-29       Impact factor: 17.440
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.